Skip to main content

Merck looks to join the obesity drug frenzy

By Bloomberg.com  
   January 05, 2024

Merck & Co. is seeking new obesity-fighting drugs called GLP-1s, joining a host of companies angling for a slice of the exploding market.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.